Background: Little information is available on geographic disparity of human papillomavirus (HPV) vaccination among women aged 18 -26 years in the U.S. Genital HPV is the most common sexually transmitted infection in the U.S. Persistent HPV infection with oncogenic types can cause cervical cancer.
Introduction
G enital human papillomavirus (HPV) is the most common sexually transmitted infection in the U.S. 1 Persistent HPV infection with oncogenic types can cause cervical cancer. The fırst HPV vaccine was licensed in 2006; that same year, the Advisory Committee on Immunization Practices recommended routine HPV vaccination of girls aged 11 or 12 years, and catch-up vaccination for girls aged 13-26 years. 2 Although HPV vaccination initiation reached 48.7% among girls aged 13-17 years, 3 only 20.7% of women aged 19 -26 years received one or more doses of HPV vaccine in 2010. 4 Demographic, health-related, and healthcare utilization characteristics have been found to be correlated with HPV vaccination disparity in these two populations. [5] [6] [7] [8] [9] [10] [11] Research on geographic variability of HPV vaccination has been limited to girls aged 13-17 years. HPV vaccination coverage was found to be lower among girls living in the southeastern U.S. compared with those living in other regions. 3 The current study is the fırst, to the authors' knowledge, to examine whether initiation of the HPV series among U.S. women aged 18 -26 years varies by geographic region. The results provide critical information for the development of targeted strategies to increase HPV vaccination initiation among young women. 
Methods
This study utilized data collected from the 2010 National Health Interview Survey (NHIS). 12 The current study initially included 2011 women aged 18 -26 years who participated in the 2010 NHIS Cancer Control Module Supplement. 12 The response of ever received HPV vaccine was used as the study's outcome variable of HPV series initiation. Individuals (144) in the response categories of unknown-refused, unknown-not ascertained, and unknowndon't know were excluded from the study. The resulting sample consisted of 1867 women. In addition to the "region" variable, the study also examined the influence of demographic characteristics, as well as variables related to women's health, other health issues, and healthcare utilization ( Table 1) .
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Data Analysis
The 2010 NHIS data were collected using a stratifıed, multistage, cluster sampling design, oversampling for minorities (blacks, Hispanics, and Asians). Both bivariate and multivariable analyses were weighted for the probability of selection and accounted for the complex sample design of NHIS.
13 Analyses were performed in 2012 using SAS, version 9.3.
In bivariate analyses, unadjusted weighted ORs were obtained to determine the relationship between the individual independent variables and HPV series initiation. A multivariable logistic regression model and its corresponding adjusted ORs assessed the characteristics that were associated independently with initiation of the HPV series among women aged 18 -26 years. Initially, the model was fıt maintaining all variables (Table 1) ; the-least signifıcant nondemographic variables with p-value Ͼ0.05 were then removed one at a time from the model. The fınal model retained all demographic variables as well as all signifıcant nondemographic variables.
Results
Of the 1867 women included in the study, 408 (21.9%) had initiated the HPV three-dose vaccine series. To ensure an adequate number of subjects within each age category for analyses, subjects who were close in age were pooled if they did not have signifıcantly different HPV series initiation rates. The distribution of characteristics, as well as the unadjusted and adjusted weighted ORs, is shown in Table 1 .
The adjusted ORs for the sample showed that women aged 18 -26 years who lived in the West and North Central U.S./Midwest were more likely to receive HPV vaccine than Northeastern residents. In addition, Hispanics were slightly more likely to initiate the HPV series than non-Hispanic whites. Women who were single and never married were more than twice as likely to initiate the HPV series than those who were married or living with a partner. Those who had never had children or who had a history of HPV infection were more likely to initiate the HPV series. Current alcohol use was associated with a higher likelihood of initiating the HPV series.
In contrast, older age was associated with a lower likelihood of initiating the HPV series in women aged 18 -26 years, and the lowest likelihood was reached by those aged 24 -25 years. Those who were uninsured, whose family income was below 200% of the federal poverty index, or who did not have a high school degree were less likely to initiate the HPV series. Women who were not current hormone-based birth control users or whose last Pap was Ͼ1 year ago were less likely to have initiated the series. As for healthcare utilization, having no regular provider, having last visited a clinic Ͼ12 months ago, and having not received a hepatitis B vaccine were correlated with not having initiated the HPV series.
Discussion
After adjusting for other characteristics, women living in the West and North Central U.S./Midwest had 54% and 20% greater odds, respectively, of initiating the HPV series, compared with those living in the Northeast. The current study is the fırst to demonstrate disparity in HPV vaccine uptake by region of residence for women aged 18 -26 years.
In a previous study, geographic disparity in the HPV vaccination was examined among girls aged 13-17 years in six U.S. states.
14 It found that girls in states with higher poverty levels were less likely to be vaccinated. In contrast, it also found that girls in counties with higher poverty levels and in the lowest-income families were more likely to be vaccinated, which the current authors believe is due to the Vaccines for Children (VFC) program. The VFC program provides HPV vaccines only to girls aged Ͻ19 years in low-income families. Low-income or uninsured women aged 19 -26 years are therefore not eligible.
A similar result was found in the present study; after adjusting for other characteristics, women aged 18 years were two to six times more likely to initiate the HPV series than those aged 19 -26 years. Further, this study showed that living 200% below the poverty level and having no insurance were both barriers to initiating the HPV series among women aged 18 -26 years. [7] [8] [9] [10] Geographic variability in HPV vaccination initiation observed in the current study may be due to regional variability of providers' recommendations regarding HPV vaccination, as well as women's knowledge about HPV and HPV vaccines.
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Limitations
The current study has several limitations. First, the crosssectional study design precludes causal inference. Second, self-reported data could be subject to recall bias. Third, bias may exist for non-inclusion of households without landline telephones. People living in households without landline telephones tend to be younger, lowincome, and from minority groups. 17 Despite these limitations, the primary strength of this study is that it is the fırst, to our knowledge, that uses a nationally representative sample to examine geographic disparity of HPV series initiation among women aged 18 -26 years.
Conclusion
The current fındings demonstrate geographic disparity of HPV series initiation among women aged 18 -26 years. Future research is needed to understand why geographic disparity exists. Evaluation of vaccination policies and practices associated with higher coverage might help characterize effective methods to improve HPV vaccination among women aged 18 -26 years.
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